ストックスクリーナーアプリを入手
3.41
0.29%
0.01
アフターアワーズ：
3.47
0.06
+1.76%
Relay Therapeutics Inc (RLAY) 最新ニュース
Relay Therapeutics shares fall 2.45% intraday as Piper Sandler initiates coverage on Bicara Therapeutics. - AInvest
Raymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost Cuts - Yahoo Finance
Published on: 2025-08-15 19:49:23 - beatles.ru
Relay Therapeutics Soars 13.57% on Earnings Beat - AInvest
Moving Average Crossover Confirms Uptrend in Relay Therapeutics Inc.July 2025 Intraday Action & Weekly Return Optimization Alerts - metal.it
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates - ADVFN Brasil
Relay Therapeutics’ SWOT analysis: AI-driven biotech’s stock faces pivotal phase - Investing.com India
Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: 89bio (ETNB), Relay Therapeutics (RLAY) and Ironwood Pharma (IRWD) - The Globe and Mail
Relay Therapeutics (RLAY) Receives Buy Rating from Leerink Partners with $12.00 Price Target - AInvest
Relay Therapeutics Reports Q2 2025 Financial Results and Progress - TipRanks
Raymond James Keeps 'Strong Buy' Rating on Relay Therapeutics but Lowers Price Target to $19 - AInvest
Will Relay Therapeutics Inc. continue its uptrendReal Time Growth Signal with Smart Setup - Newser
A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $17 to $19 - 富途牛牛
Why Relay Therapeutics Inc. stock attracts strong analyst attentionGrowth Watchlist for Long Term Positioning - Newser
Screener Results Flag Relay Therapeutics Inc. as OversoldReal-Time Market Sentiment Tracking Gains Momentum - beatles.ru
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down After Analyst Downgrade - Defense World
Relay Therapeutics: Raymond James Maintains Strong Buy, PT Down to $19. - AInvest
RLAY.O Drops 11.7%: Uncovering the Forces Behind the Sudden Move - AInvest
A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $4 to $17 - 富途牛牛
Wells Fargo reiterates Equal Weight rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
Relay Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Relay Therapeutics reports Q2 EPS (41c), consensus (47c) - TipRanks
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Evaluating Relay Therapeutics' Momentum: Strategic Execution and Pipeline Progress in Q2 2025 - AInvest
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus
Barclays Reiterates a Buy Rating on Relay Therapeutics (RLAY) - MSN
What’s the recovery path for long term holders of Relay Therapeutics Inc.Free Capital Preserving Trade Plan Templates - Newser
Relay Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowMomentum Screener with Buy and Sell Areas - Newser
Relay Therapeutics Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Barclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - MSN
Relay Therapeutics (RLAY) Expected to Announce Earnings on Thursday - Defense World
We're Keeping An Eye On Relay Therapeutics' (NASDAQ:RLAY) Cash Burn Rate - 富途牛牛
What makes Relay Therapeutics Inc. stock price move sharplyUnprecedented profits - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
How does Relay Therapeutics Inc. generate profit in a changing economyOutstanding stock performance - Jammu Links News
Should I hold or sell Relay Therapeutics Inc. stock in 2025Build a winning investment strategy today - Jammu Links News
Is Relay Therapeutics Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com
What are the latest earnings results for Relay Therapeutics Inc.Unlock exclusive stock market insights - Jammu Links News
Why is Relay Therapeutics Inc. stock attracting strong analyst attentionStay ahead with daily expert stock picks - Jammu Links News
Critical Survey: SHINECO (NASDAQ:SISI) vs. Relay Therapeutics (NASDAQ:RLAY) - Defense World
What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Discover stocks with superior performance - Jammu Links News
What drives Relay Therapeutics Inc. stock priceMaximize portfolio growth with professional advice - Jammu Links News
How does Relay Therapeutics Inc. compare to its industry peersGet alerts on high-potential market moves - Jammu Links News
Relay Therapeutics (RLAY): Is H2 2025 the Inflection Point for AI-Driven Drug Discovery? - AInvest
Relay Therapeutics: What's Next For H2 2025? - Seeking Alpha
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 - 富途牛牛
Relay Therapeutics Q2 2025 Financial Results and Corporate Highlights Announced for August 7, 2025 - AInvest
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment - TipRanks
1.55%
0.38%
大文字化:
|
ボリューム (24 時間):